tiprankstipranks
Trending News
More News >
Dianthus Therapeutics (DNTH)
NASDAQ:DNTH
US Market

Dianthus Therapeutics (DNTH) Income Statement

Compare
402 Followers

Dianthus Therapeutics Income Statement

Last quarter (Q3 2025), Dianthus Therapeutics's total revenue was $396.00K, a decrease of -81.77% from the same quarter last year. In Q3, Dianthus Therapeutics's net income was $-36.77M. See Dianthus Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 6.24M$ 2.83M$ 6.42M$ 1.48M$ 0.00
Gross Profit
$ 6.24M$ 2.83M$ 6.42M$ 1.48M$ -1.98M
Operating Expenses
$ 108.10M$ 51.00M$ 36.12M$ 14.56M$ 76.72M
Depreciation and Amortization
$ 412.00K$ 355.00K$ 147.00K$ 0.00$ 1.98M
EBITDA
$ -101.45M$ -47.82M$ -29.56M$ -13.09M$ -72.96M
Operating Income
$ -101.86M$ -48.17M$ -29.70M$ -13.09M$ -78.70M
Other Income/Expenses
$ 16.89M$ 4.62M$ 1.23M$ -23.00K$ 3.77M
Pretax Income
$ -84.97M$ -43.55M$ -28.48M$ -13.11M$ -74.94M
Net Income
$ -84.97M$ -43.55M$ -28.48M$ -13.11M$ -74.94M
Per Share Metrics
Basic EPS
$ -2.55$ -8.45$ -7.60$ -3.82$ -27.30
Diluted EPS
$ -2.55$ -8.45$ -7.60$ -3.82$ -27.30
Weighted Average Shares Outstanding
33.31M 5.15M 3.75M 3.43M 2.75M
Weighted Average Shares Outstanding (Diluted)
33.31M 5.15M 3.75M 3.43M 2.75M
Currency in USD

Dianthus Therapeutics Earnings and Revenue History